Cassady Schiller Wealth Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$6.23K Buy
59
+16
+37% +$1.72K ﹤0.01% 384
2024
Q3
$4.64K Hold
43
﹤0.01% 353
2024
Q2
$4.67K Hold
43
﹤0.01% 351
2024
Q1
$5.67K Buy
43
+3
+8% +$375 ﹤0.01% 363
2023
Q4
$4.87K Hold
40
﹤0.01% 361
2023
Q3
$4.49K Hold
40
﹤0.01% 378
2023
Q2
$5.82K Hold
40
﹤0.01% 375
2023
Q1
$5.17K Hold
40
﹤0.01% 357
2022
Q4
$5.1K Buy
+40
New +$4.64K ﹤0.01% 365
2022
Q1
Sell
-44
Closed -$5K 627
2021
Q4
$5K Buy
+44
New +$5.76K ﹤0.01% 359

Other funds holding ZBH

Cassady Schiller Wealth Management's ZBH Position: Q4 2024 in Review

Cassady Schiller Wealth Management increased its Zimmer Biomet (ZBH) stake by 37% in Q4 2024, buying an estimated $1.72K and bringing the position to 59 shares worth $6.23K. The position accounts for ﹤0.01% of the portfolio, ranked #384.

Cassady Schiller Wealth Management first reported a position in ZBH in Q4 2021 and has held it in 10 quarters since. 1,027 funds tracked by Wall St. Rank hold ZBH as of Q4 2024.

  • Cassady Schiller Wealth Management held 59 shares of Zimmer Biomet worth $6.23K as of Q4 2024.
  • Cassady Schiller Wealth Management bought 16 Zimmer Biomet shares in Q4 2024, an estimated $1.72K.
  • Zimmer Biomet made up ﹤0.01% of Cassady Schiller Wealth Management's portfolio in Q4 2024, its #384 holding.
  • Cassady Schiller Wealth Management first reported a position in Zimmer Biomet in Q4 2021 and has held it in 10 quarters since.
  • 1,027 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2024.

Based on Cassady Schiller Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.